SLC5A2 and diabetes mellitus: Similarly, a study assessing the safety of the combined use of SGLT2 inhibitors and diuretics in patients with diabetes mellitus also reported a significantly increased incidence of volume depletion in those receiving high-dose diuretics exceeding 40 mg/day of furosemide equivalent [30].